Differential contributions of Caenorhabditis elegans histone deacetylases to Huntingtin polyglutamine toxicity

被引:122
作者
Bates, EA
Victor, M
Jones, AK
Shi, Y
Hart, AC
机构
[1] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
关键词
Huntington; polyglutamine; HDAC; polyQ; neurodegeneration; CBP;
D O I
10.1523/JNEUROSCI.3344-05.2006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Expansion of a polyglutamine tract in the huntingtin protein causes neuronal degeneration and death in Huntington's disease patients, but the molecular mechanisms underlying polyglutamine-mediated cell death remain unclear. Previous studies suggest that expanded polyglutamine tracts alter transcription by sequestering glutamine rich transcriptional regulatory proteins, thereby perturbing their function. We tested this hypothesis in Caenorhabditis elegans neurons expressing a human huntingtin fragment with an expanded polyglutamine tract (Htn-Q150). Loss of function alleles and RNA interference (RNAi) were used to examine contributions of C. elegans cAMP response element-binding protein (CREB), CREB binding protein (CBP), and histone deacetylases (HDACs) to polyglutamine-induced neurodegeneration. Deletion of CREB (crh-1) or loss of one copy of CBP (cbp-1) enhanced polyglutamine toxicity in C. elegans neurons. Loss of function alleles and RNAi were then used to systematically reduce function of each C. elegans HDAC. Generally, knockdown of individual C. elegans HDACs enhanced Htn-Q150 toxicity, but knockdown of C. elegans hda-3 suppressed toxicity. Neuronal expression of hda-3 restored Htn-Q150 toxicity and suggested that C. elegans HDAC3 (HDA-3) acts within neurons to promote degeneration in response to Htn-Q150. Genetic epistasis experiments suggested that HDA-3 and CRH-1 (C. elegans CREB homolog) directly oppose each other in regulating transcription of genes involved in polyglutamine toxicity. hda-3 loss of function failed to suppress increased neurodegeneration in hda-1/+; Htn-Q150 animals, indicating that HDA-1 and HDA-3 have different targets with opposing effects on polyglutamine toxicity. Our results suggest that polyglutamine expansions perturb transcription of CREB/CBP targets and that specific targeting of HDACs will be useful in reducing associated neurodegeneration.
引用
收藏
页码:2830 / 2838
页数:9
相关论文
共 61 条
[1]   Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells [J].
Ajamian, F ;
Salminen, A ;
Reeben, M .
NEUROSCIENCE LETTERS, 2004, 365 (01) :64-68
[2]  
Baran R, 1999, DEVELOPMENT, V126, P2241
[3]   Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin [J].
Boutell, JM ;
Thomas, P ;
Neal, JW ;
Weston, VJ ;
Duce, J ;
Harper, PS ;
Jones, AL .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1647-1655
[4]   THE SIR2 GENE FAMILY, CONSERVED FROM BACTERIA TO HUMANS, FUNCTIONS IN SILENCING, CELL-CYCLE PROGRESSION, AND CHROMOSOME STABILITY [J].
BRACHMANN, CB ;
SHERMAN, JM ;
DEVINE, SE ;
CAMERON, EE ;
PILLUS, L ;
BOEKE, JD .
GENES & DEVELOPMENT, 1995, 9 (23) :2888-2902
[5]  
BRENNER S, 1974, GENETICS, V77, P71
[6]   Transcriptional dysregulation in Huntington's disease [J].
Cha, JHJ .
TRENDS IN NEUROSCIENCES, 2000, 23 (09) :387-392
[7]  
Choi KY, 2002, BIOCHEM BIOPH RES CO, V293, P1295, DOI 10.1016/S0006-291X(02)00374-1
[8]   The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg [J].
Ciechanover, A ;
Brundin, P .
NEURON, 2003, 40 (02) :427-446
[9]   Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate [J].
Dangond, F ;
Gullans, SR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (03) :833-837
[10]   Functional requirement for histone deacetylase 1 in Caenorhabditis elegans gonadogenesis [J].
Dufourcq, P ;
Victor, M ;
Gay, F ;
Calvo, D ;
Hodgkin, J ;
Shi, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (09) :3024-3034